Association of Microbiota and Overactive Bladder: A Mini Literature Review

Document Type : Review


1 Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Pathology, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3 Urology and Nephrology Research Center, Hamadan University of Medical Science, Hamadan, Iran

4 Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

5 Medicine Department, Isfahan University of Medical Sciences, Isfahan, Iran


Overactive bladder (OAB) is a common urinary disorder that affects both sexes. This disorder has a very strong and direct effect on the quality of the personal and social life of patients. Some recent studies have shown that urine and urinary tract are not sterile and contain special microbiota (communities of special microorganisms that are found in and on an individual). Thus, the goal of this review was to answer the question of whether microbiota can lead to the overactive bladder.


  • The urine and urinary tract are not sterile and contain special microbiota.
  • Some unique bacterial strains were identified in overactive bladder patients.
  • Microbiota is associated with overactive bladder and can be one of the causes of it.



It is well known that microbes and humans have closely related and healthy body have a variety of microorganisms (1, 2). Microbes play a significant role in human health and disease and can cause homeostasis in the body or activities such as metabolism and defense (3). Today, the terms “microbiome” and “microbiota” are widely used in clinical science. Microbiota refers to the collection of microorganisms that reside in the part of the body, while microbiome means that the pool of genomes and genes of the microorganisms that live in the host (4).

In 2008, the national institutes of health conducted the human microbiome project (HMP) to study the human microbiome in 242 healthy individuals (5). In this interdisciplinary project, the microbiome of different sites of the body (including skin, gastrointestinal (GI) tract, oral cavity, nasal cavity, and vagina) was examined and its relationship with human health and disease was analyzed (5). Initially, urine and urinary track were not included in the HMP studies. One of the reasons for this was that urinary tracts were maintained sterile and it was thought that urinary disorders were caused by the invasion of an external pathogen (6).

For many years, the concept of microbiology was based on the technique of bacterial culture. Accordingly, the presence of bacteria was confirmed if the culture was positive. Currently, with the advent of methods beyond culture, the presence of bacteria in the various parts of the body has been identified even under health conditions. Methods such as metagenomic analysis of bacteria have led to the discovery of the presence of hard or slow-growing bacteria in areas that were considered sterile (7-9).


Microbiota and the Urinary Tract

Advances in quantitative urine culture (EQUC), 16S rRNA and metagenomic sequencing have led to an increase in knowledge of the specific microbiota of urine (9-12). In such studies, urine is taken directly from the bladder (with direct suprapubic aspiration) so that the examined microbiota is exclusively related to the urine and is not contaminated (9). The EQUC technique helps to examine live bacteria, which were not identified by traditional cultures (12). Because this culture technique uses a large amount of urine in specific culture media and temperatures (13). Also, due to the 16S rRNA gene is highly conserved; it is a good target for bacterial sequencing. Because the presence of 9 hypervariable gene regions (V1-V9) in this conserved gene makes it possible to classify the bacteria in the sample by sequencing even one region of these genes (14, 15). The stages of urinary microbiota analysis are shown schematically in Figure 1. Therefore, with the help of these methods, live hard/slow bacteria could be evaluated in the urine and the microbiota pattern of urine and urinary tract were determined (12). This microbiota pattern plays an important role in urinary tract health and disease (8, 16, 17). The association of microbiota with urinary tract health/disease is directly affected by microbiota changes in a variety of conditions, including seasonal, geographical, and nutritional conditions (3). Therefore, by targeting specific microorganisms present in the urinary system and their environmental conditions, more efficient diagnosis and treatment can be achieved.


 Figure 1: Schematic steps of the urine microbiota examination



Urinary Microbiota and the Overactive Bladder

Recent studies have shown that alterations in the urinary microbiota can be associated with many urological diseases, such as the overactive bladder, interstitial cystitis, chronic prostatitis, and bladder cancer (14, 16, 18).

The international continence society (ICS) defines overactive bladder (OAB) as the sudden urge to urinate, with or without urge incontinence, often accompanied by frequency and nocturia in the absence of identifiable causes such as urinary tract infection (19, 20). OAB has been seen in both sexes and its prevalence increases with aging (21).

In addition to the financial burden, OAB has an adverse effect on people's quality of life, sexual function, sleep, and physical and social activities. Also, it affects people's mental health due to disappointment, anxiety, shame, and stress (22, 23). OAB diagnosis does not have a standard procedure and is performed only by physical examination and voiding diary. However, the possibility of infection and abnormal pathology of the urinary tract should be excluding (14).

The etiology and effective treatment of the OAB is not yet fully clear. Possible causes are neuromuscular and muscarinic receptor dysfunction, but given that in many OAB patients anti-muscarinic receptor, Botox, or other treatments are ineffective. Therefore, OAB can be caused by other reasons or a complex of reasons and microbiota can be one of them (17, 24, 25). The articles related to the relationship between microbiota and active bladder, which are reviewed in this study, are summarized in Table 1.


  Table 1. Summary of publications, addressing the role of urinary microbiota in OAB patients


Sample size


Sample collection

Analysis technique


Main finding


Hilt et al., 2014 (24)

41 OAB women and 24 health women


Transurethral catheterization

EQUC1 and 16S rRNA sequencing

Common genera:

Lactobacillus, Corynebacterium, Streptococcus, Actinomyces, Staphylococcus, Aerococcus,

Gardnerella, Bifidobacterium, Actinobaculum

Uniqe genera in OAB group:

Aerococcus and Actinobaculum

Siddiqui et al., 2014 (26)

Two samples from one OAB woman




Not described

16S rDNA sequencing

Streptococcus, Atopobium, Ureaplasma, Prevotella, Bacteroides

Wu et al., 2017 (27)

30 OAB women and 25 health women




16S rRNA sequencing

Decreased genera in the OAB group:

Prevotella, Dialister, Fusobacterium, Jonquetella, Campylobacter, Finegoldia, Anaerococcus, Lactobacillu, Pyramidobacter, Ureaplasma, Enterococcus, Novosphingobium, and Lactococcus

Increased genera in the OAB group:

Sneathia, Staphylococcus, Proteus, Helcococcus, Gemella, Mycoplasma, and Aerococcus

Gill et al., 2018 (28)

24 OAB women and 22 health women


MSU2 collection

Urothelial-cell-sediment culture

Common bacteria in OAB group:

E. coli, Enterococcus faecalis, Proteus, Klebsiella, Enterobacter, Serratia and Pseudomonas

Common bacteria in health group:

Staphylococcus, Streptococcus, Citrobacter and Lactobacillus

Perovic et al., 2019 (29)

6 OAB women


MSU2 collection

Optimized CULT and 16s rRNA sequencing


Common bacteria:

Bifidobacterium species  and Corynebacterium aurimucosum

Common bacteria in sever OAB patiants:

Gardnerella vaginalis  and Ureaplasma urealyticum

EOUC: Enhanced Quantitative Urine Culture; MSU: Midstream Specimen of Urine; OAB: Over Active Bladder


Hilt and colleagues used 16S rRNA gene sequencing and an EQUC protocol to examine live bacteria in the urine of 41 women with OAB and 24 healthy women. According to the EQUC technique, there were 52 positive culture samples (80%), while 92% of them were negatively reported by the standard culture protocol. Among the isolated genera, Lactobacillus (15%) was the most prevalent followed by Corynebacterium (14.2%), Streptococcus (11.9%), Actinomyces (6.9%), and Staphylococcus (6.9%). In patients with OAB, Aerococcus and Actinobaculum were unique genera that were not seen in normal samples. The Hilt study showed that urine contains live bacteria that originate from its microbiota and can be unique in OAB (24).

In 2014, another study was performed on a 61-year-old woman who had urinary symptoms and OAB for many years. In the first stage, bacteriuria (Streptococcus) was diagnosed with standard bacterial cultures and treated with antibiotics. By performing culture-independent 16S rDNA sequencing on the woman's urine, a set of different bacteria, including fastidious bacteria, were identified. A year later, the patient was re-examined for severe urinary symptoms and no infection was reported by standard culture methods. But, the 16S rDNA results showed the same pattern as last year. Due to negative urine culture, the persistence of urinary symptoms, and the similarity of 16S rDNA results with the previous year, the association between microbiota and OAB becomes stronger (26).

In 2017, Wu and colleagues studied urinary microbiota in people with OAB. In this study, the urine of 30 patients with OAB and 25 healthy individuals (none of them had a urinary tract infection) were analyzed. 16S rRNA Sequencing results showed that 13 genera, including Prevotella, Dialister, Fusobacterium, Jonquetella, Campylobacter, Finegoldia, Anaerococcus, Lactobacillus, Pyramidobacter, Ureaplasma, Enterococcus, Novosphingobium, and Lactococcus were decreased in the OAB patients compared to the control group. In contrast, seven genera including Sneathia, Staphylococcus, Proteus, Helcococcus, Gemella, Mycoplasma, and Aerococcus in the OAB group were increased compared to the control group. Hence, there was a significant difference between the microbiota of the OAB group and the control. The results of this study showed that certain species, such as Aerococcus, were associated with some specific urinary symptoms. Also, urinary microbiota in OAB people is less diverse and is poorer in lactobacilli than in normal people. Finally, Wu et al., concluded that the high diversity and dominance of Lactobacillus in microbiota were two protective factors against OAB (27).

In another study, urinary tract microbiology activity was evaluated for 12 months in OAB patients and the control group. Microbial evaluation in this study was performed using the culture of urothelial cells from the urine sediment and its results were compared with the standard culture method. Among patients with OAB, E. coli was the most common species, followed by Enterococcus faecalis, Proteus, Klebsiella, Enterobacter, Serratia, and Pseudomonas. On the other hand, the most common species in the control group were Staphylococcus, Streptococcus, Citrobacter, and Lactobacillus. In this study, there are recurring and consistent differences in microbial load and dispersion of isolated species in the OAB and control group. The difference in the amount and type of bacterial colonization in the patients and healthy individuals indicates the effect of urinary tract microbiota on the incidence and severity of the disease (28).

In 2019, urinary microbiota in six OAB patients without urinary tract infection was examined using optimized CULT and 16S rRNA sequencing by Gill et al., These methods detected a very large number of bacteria in all patients with no criteria for urinary tract infection, which was related to 36 bacterial genera. Most of these bacteria are related to urinary tract infections, while standard culture methods have not been able to detect them. The most common bacteria in this study were Bifidobacterium species (28%) and Corynebacterium aurimucosum (22%). In patients with severe symptoms of OAB, Gardnerella vaginalis (46%) and Ureaplasma urealyticum (44%) were more common. Finally, Gill et al., conclude that urinary microbiota analysis is required to diagnosis and treatment of OAB using new culture and sequencing methods (29).



Today, it has been proven that urine and urinary tract are not sterile and have unique microbiota. These studies provide strong evidence that urinary microbiota changes in OAB patients. Therefore, the urinary microbiota was associated with OAB and may be used as a diagnostic and therapeutic marker. Studies with a large sample size can lead to a microbiota signature in OAB disease that can even distinguish between the disease and other urinary tract diseases with overlapping symptoms.


Authors' contributions

All authors contributed equally.



Special thanks to Urology Research Center (URC), Tehran University of Medical Sciences, Tehran, Iran. 


Conflict of interest

All authors claim that there is no competing interest in this case report of surgery.



There was no founding. 


Ethics statement

Not applicable.



EQUC      Quantitative urine culture

GI             Gastrointestinal

HMP         Human microbiome project

ICS           International continence society

OAB         Overactive bladder

1.            Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annual Review of Pathology: Mechanisms of Disease. 2012;7:99-122.
2.            Cénit M, Matzaraki V, Tigchelaar E, Zhernakova A. Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2014;1842(10):1981-92.
3.            Falony G, Vandeputte D, Caenepeel C, Vieira-Silva S, Daryoush T, Vermeire S, et al. The human microbiome in health and disease: hype or hope. Acta Clinica Belgica. 2019;74(2):53-64.
4.            Mueller ER, Wolfe AJ, Brubaker L. Female urinary microbiota. Current opinion in urology. 2017;27(3):282-6.
5.            Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-14.
6.            Alfano M, Canducci F, Nebuloni M, Clementi M, Montorsi F, Salonia A. The interplay of extracellular matrix and microbiome in urothelial bladder cancer. Nature Reviews Urology. 2016;13(2):77-90.
7.            DiGiulio D. Diversity of microbes in amniotic fluid. Seminars in fetal & neonatal medicine. 2012;17:2-11.
8.            Thomas-White K, Brady M, Wolfe AJ, Mueller ER. The bladder is not sterile: History and current discoveries on the urinary microbiome. Curr Bladder Dysfunct Rep. 2016;11(1):18-24.
9.            Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, FitzGerald M, et al. Evidence of Uncultivated Bacteria in the Adult Female Bladder. Journal of Clinical Microbiology. 2012;50(4):1376-83.
10.          Lewis D, Brown R, Williams J, White P, Jacobson S, Marchesi J, et al. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Frontiers in Cellular and Infection Microbiology. 2013;3(41).
11.          Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, et al. The Female Urinary Microbiome: a Comparison of Women with and without Urgency Urinary Incontinence. mBio. 2014;5(4):e01283-14.
12.          Price T, Dune T, Hilt E, Thomas-White K, Kliethermes S, Brincat C, et al. The Clinical Urine Culture: Enhanced Techniques Improve Detection of Clinically Relevant Microorganisms. Journal of Clinical Microbiology. 2016;54:JCM.00044-16.
13.          Kogan MI, Naboka YL, Ibishev KS, Gudima IA, Naber KG. Human urine is not sterile-shift of paradigm. Urologia internationalis. 2015;94(4):445-52.
14.          Antunes-lopes T, Vale L, Coelho A, Martins-Silva C, Rieken M, Geavlete B, et al. The Role of Urinary Microbiota in Lower Urinary Tract Dysfunction: A Systematic Review. European Urology Focus. 2018;6.
15.          Thomas-White KJ, Hilt EE, Fok C, Pearce MM, Mueller ER, Kliethermes S, et al. Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J. 2016;27(5):723-33.
16.          Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract—a role beyond infection. Nature Reviews Urology. 2015;12(2):81-90.
17.          Schneeweiss J, Koch M, Umek W. The human urinary microbiome and how it relates to urogynecology. Int Urogynecol J. 2016;27(9):1307-12.
18.          Bi H, Tian Y, Song C, Li J, Liu T, Chen Z, et al. Urinary microbiota – a potential biomarker and therapeutic target for bladder cancer. Journal of Medical Microbiology. 2019;68(10):1471-8.
19.          Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Neurourology and Urodynamics. 2002;21(2):167-78.
20.          Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics. 2010;29(1):4-20.
21.          Tubaro A. Defining overactive bladder: epidemiology and burden of disease. Urology. 2004;64(6):2-6.
22.          Reynolds WS, Fowke J, Dmochowski R. The Burden of Overactive Bladder on US Public Health. Curr Bladder Dysfunct Rep. 2016;11(1):8-13.
23.          Stewart WF, Van Rooyen, J. B., Cundiff, G. W., Abrams, P., Herzog, A. R.,, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World Journal of Urology. 2003;20:327–36.
24.          Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. Journal of clinical microbiology. 2014;52(3):871-6.
25.          Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment. The Journal of Urology. 2015;193(5):1572-80.
26.          Siddiqui H, Lagesen K, Nederbragt AJ, Eri LM, Jeansson SL, Jakobsen KS. Pathogens in Urine from a Female Patient with Overactive Bladder Syndrome Detected by Culture-independent High Throughput Sequencing: A Case Report. Open Microbiol J. 2014;8:148-53.
27.          Peng Wu YC, Jie Zhao, Guihao Zhang, Jiawei Chen, Junpeng Wang and, Zhang H. Urinary Microbiome and Psychological Factors in Women with Overactive Bladder. Frontiers in Cellular and Infection Microbiology. 2017;7.
28.          Gill K, Kang R, Sathiananthamoorthy S, Khasriya R, Malone-Lee J. A blinded observational cohort study of the microbiological ecology associated with pyuria and overactive bladder symptoms. Int Urogynecol J. 2018;29(10):1493-500.
29.          Perovic SU, Ksiezarek M, Rocha J, Vale L, Silva C, Dinis P, et al. Time to change microbiological approach to overactive bladder. European Urology Supplements. 2019;18(1):e103.